Dividends Inside 
iShares Genomics Immunology and Healthcare ETF
IDNA
$35.42 (+ $0.22 + 0.62%)
Last updated: 2026-08-13 07:51 UTC
iShares Genomics Immunology and Healthcare ETF trades under ticker IDNA on NYSE as an ETF. Use this page to review its market price, share price, dividends, and price history. The page also shows Health exposure. Identifiers: ISIN US46435U1925, CUSIP 46435U192.
Related researchIDNA ETF priceIDNA share priceIDNA dividend historyIDNA dividend yieldiShares Genomics Immunology and Healthcare ETF dividend historyiShares Genomics Immunology and Healthcare ETF dividend yield46435U192iShares Genomics Immunology and Healthcare ETFiShares Genomics Immunology and Healthcare ETF share price
About the Company
The iShares Genomics Immunology and Healthcare ETF is an exchange-traded fund that provides exposure to global companies at the forefront of genomics, immunology, and bioengineering innovation. The fund tracks a market-cap-weighted index of firms involved in these rapidly advancing fields, spanning the full value chain from research and development to commercialization. Its portfolio is heavily concentrated in the healthcare sector, with a focus on companies driving breakthroughs in genetic therapies, immunotherapies, and advanced biopharmaceuticals. The ETF offers investors a way to participate in the long-term growth potential of these transformative technologies, which are reshaping medicine and healthcare delivery worldwide. Managed by BlackRock, the fund is designed for those seeking targeted exposure to the scientific and technological advancements shaping the future of health and biotechnology.